Predicting Payer Uptake with Precision
Date:
March 24, 2021
関連コンテンツ
November 5, 2026
Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk
Sponsor:
ICON
November 5, 2026
Filling the Gap: Integrating Patient-Generated Data into Real-World Evidence
Sponsor:
Veradigm
November 5, 2026
Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation
Sponsor:
The PPD clinical research business of Thermo Fisher Scientific Inc.
Panalgo, LLC
November 5, 2026
Network meta-analysis and its role in evidence-based decision-making
Sponsor:
ICON
November 5, 2026
Addressing Orphan and Rare Diseases - A Cutting Edge Conversation
Sponsor:
HealthLumen
ICON
November 5, 2026
Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases
Sponsor:
ICON
November 5, 2026
RWE reality check: Routine patient health records and regulatory requirements
Sponsor:
Cardinal Health
November 5, 2026
"S" Stands for Systematic: Demystifying the Systematic Literature Review
Sponsor:
ICON
November 5, 2026
Survival Analysis for Immature Data: A Review of Techniques and Lessons Learned
Sponsor:
ICON
November 5, 2026
The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example
Sponsor:
Panalgo, LLC
November 5, 2026
Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management
Sponsor:
OPEN Health
November 5, 2026
Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches
Sponsor:
Carelon Research
November 5, 2026
Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults
Sponsor:
ICON
November 5, 2026
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
Sponsor:
ICON
November 5, 2026
Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access
Sponsor:
PRECISIONheor
OPEN Health
PRMA Consulting
November 5, 2026
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
Sponsor:
OPEN Health
November 5, 2026
Cell & Gene Therapies - Beginning with the End in Mind
Sponsor:
Magnolia Market Access
November 5, 2026
Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases
Sponsor:
Inspire
November 5, 2026
Advancing identity data management for digital engagement: How leading organizations are doing it
November 5, 2026
Keeping up with demands for healthcare outside of the hospital: Critical ways tech supports the distributed care model
November 5, 2026
Driving value from healthcare data: How integrated cloud-based data is foundational to drive enterprise change
November 5, 2026
Connected communities: Advancing population health through data and emerging technology
November 5, 2026
From Challenges to Opportunities: Navigating the EU MDR as a Medical Device Manufacturer
November 5, 2026
HTA Implementation in the MEA Region - an Overview from WHO and Country Updates
November 5, 2026
Improving Treatment Access & Outcomes by Integrating Social Determinants of Health Data with Real-World Evidence
November 5, 2026
Webcast: Taking the Complexity Out of Leveraging Health Plan Price Transparency Data
November 5, 2026
Beyond the payment variance report: How to resolve common, costly underpayment issues
November 5, 2026
Expediting drug product development and commercialization in global markets with global filing strategies
November 5, 2026
Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making
November 5, 2026
Measuring the intangible- what is the true value of a "patient centric" initiative
November 5, 2026
The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval
November 5, 2026
Fit for Local Context? Establishing or Improving Deliberative Processes for HTA
November 5, 2026
US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th
November 5, 2026
When the Barrier to a Breakthrough Drug is You Can't Make It - September 28th
November 5, 2026
Biology's modern LIMS for labs of the future - August 17 | 12:00 pm - 1:00 pm EDT
November 5, 2026
AI and Machine Learning Technologies: The New Normal of the Pharmaceutical Industry - July 27th
November 5, 2026
Digital Transformation to Support Operational, Therapeutic and Clinical Decision Making
November 5, 2026
Become an expert & hone your skills for Pharma, Biotech, Medical & Diagnostic Device launches
November 5, 2026
It's Not FAIR! Improving Data Publishing Practices in Research-Interoperability
November 5, 2026
Exploring Best Practices and Innovation in New Registry Handbook: Part 2 - Understanding Quality
November 5, 2026
Rise of the Robots 2.0: Real Talk About Artificial Intelligence In Systematic Reviews
November 5, 2026
Informational Webinar & Alumni Panel: Online MS Degree, Pharm Outcomes & Policy
November 5, 2026
Patient-Centric RWE Research & Remote Monitored Care: Learnings from a support program leveraging telehealth & connected devices
November 5, 2026
Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation
Sponsor:
Evidera, part of PPD
November 5, 2026
Minimizing the Impact of Cross-Cultural Differences in COA Translations
Sponsor:
ICON
November 5, 2026
What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence
Sponsor:
PHAR
November 5, 2026
Finding Value in Linking Real-World Data with Social Determinants of Health
Sponsor:
Magnolia Market Access
November 5, 2026
Stay Ahead of the Game: Learn How to Conduct an Evidence-Based GVD Faster and Smarter to Improve Market Access
Sponsor:
DistillerSR
November 5, 2026
Health Economic and Outcome Research (HEOR) for Medical Technologies for the US Healthcare Systems
Sponsor:
Alira Health
November 5, 2026
Streamlining Health Technology Assessments by Automating Literature Reviews
Sponsor:
DistillerSR
November 5, 2026
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Sponsor:
Genesis Research Group
November 5, 2026
Achieving Consensus When Everyone is an Expert, but No One Agrees
Sponsor:
PHAR
November 5, 2026
Evidence Synthesis for Sparse Evidence Base, Heterogeneous Studies, and Disconnected Networks
Sponsor:
ICON
November 5, 2026
Optimize Your Value Story Through Integrated Evidence Generation - From Bench to Patient
Sponsor:
Syneos Health
November 5, 2026
Understanding Health Care Decision Maker Preferences for Optimized Engagement
Sponsor:
ICON
November 5, 2026
Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations
Sponsor:
Self Care Catalysts, an Alira Health Company
November 5, 2026
How Cerner Enviza Uses Clinical Data to Drive RWE Decisions
Sponsor:
Cerner Enviza
November 5, 2026
Optimizing Real-World Evidence for Maternal and Neonatal Outcomes
Sponsor:
HealthCore, Inc.
November 5, 2026
How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies
Sponsor:
DistillerSR
November 5, 2026
Using External Control Arm Studies in HTA Submissions: An Alternative, When RCTs are not Feasible
Sponsor:
ICON
関連コンテンツ
デモを見る
現代のライフサイエンスを支えるデジタル基盤
プロバイダー、ワークフロー、承認、コンプライアンス、データ、支出を一元管理できるインテリジェントなプラットフォームをご紹介します。複雑なプロジェクトをより迅速に、高い可視性と管理体制のもとで推進することが可能です。